Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02621307
Other study ID # GLUSEED
Secondary ID
Status Completed
Phase Phase 1
First received November 27, 2015
Last updated December 1, 2015
Start date July 2010
Est. completion date July 2011

Study information

Verified date November 2015
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether drinks containing Salvia hispanica L (Salba) or Flax lower postprandial blood glucose levels and improve appetite in healthy individuals.


Description:

Dietary fibre has been implicated in improving many risk factors associated with Type 2 Diabetes and Cardiovascular Disease (CVD). However, on average, Norther Americans consume less than half of the recommended amount set by health agencies. It has been proposed that the health benefits of dietary fibre may be attritbuted to rheological characteristics such as viscosity. Salvia hispanica L (Salba) and Flax are nutritionally similar. The primary objective of this research trial is to study the effects of Salba and Flax on postprandial glycemia and appetite in healthy individuals.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date July 2011
Est. primary completion date July 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- BMI less than 35 kg/m^2

Exclusion Criteria:

- known history of liver or kidney disease, diabetes, hypertension, stroke, or myocardial infarctions, thyroid disease, gastrointestinal disease, or AIDS

- subjects using medications or Natural Health Products

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Salba

Flax

Control


Locations

Country Name City State
Canada St. Michael's Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Postprandial Blood Glucose At each visit, postprandial blood glucose will be measured via capillary blood samples, at 15, 30, 45, 60, 90, and 120 minutes after intake of test meals 2 Hours No
Secondary Change in Subjective Satiety At each visit, subjective satiety (how hungry/full you feel) will be measured via questionnaires, at 15, 30, 45, 60, 90, and 120 minutes after intake of test meals 2 Hours No
See also
  Status Clinical Trial Phase
Completed NCT01684332 - Postprandial Response to Different Jams N/A
Completed NCT03730727 - Exercise-meal Timing and Postprandial Glucose Control N/A
Completed NCT03242876 - The Effects of Citric and Malic Acid Found in Pomegranate Juice on Glycaemic Response to White Bread. N/A
Completed NCT05152745 - Effect of Ginger Extract on Postprandial Glycaemia of Healthy Adults and Its Antioxidant Properties N/A
Terminated NCT04298710 - Effects of Arm Cycling and Leg Cycling on Postprandial Blood Glucose Levels in Healthy Persons N/A
Recruiting NCT06444984 - The Movie Theater Study N/A
Enrolling by invitation NCT02488018 - Investigation of the Glycemic Index of Ethiopian Honey Phase 0
Completed NCT04655131 - Effect of Protein Intake on Post Prandial Hyperglycemia in Children and Adolescents With Type1 Diabetes Mellitus N/A
Completed NCT04914416 - Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects N/A
Recruiting NCT05774613 - Effect of Hibiscus Sabdariffa Beverage N/A
Completed NCT05140629 - Effect of Baobab Fruit on Postprandial Glycaemia in Healthy Adults N/A
Completed NCT03817749 - Ketone Supplementation, Glucose Control, and Cardiovascular Function N/A
Completed NCT04163874 - Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas N/A
Terminated NCT04079881 - Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes Phase 1/Phase 2
Recruiting NCT06241976 - Diabetes Risk in East London and Its Association With Vitamin D by Ethnic Group (DELVE) N/A
Completed NCT02930681 - Efficacy of Glucosanolâ„¢ in Reducing Post-prandial Glucose Levels in Overweight Subjects N/A
Active, not recruiting NCT04730882 - Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults
Completed NCT05528874 - NUTRACORE, Glycaemic Index and Appetite N/A
Recruiting NCT03255876 - Effects of Enriched Fruit Juice on Blood Glucose Levels After a Meal in Healthy Subjects N/A